Vascular Pharmaceuticals Receives $9,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
    Vascular Pharmaceuticals
  • Mailing Address
    510 Meadowmont Village Way Chapel Hill, NC 27517 USA
  • Company Description
    Vascular Pharmaceuticals, Inc. is focused on the development and commercialization of novel therapeutics targeting the treatment of diabetes associated complications.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    The financing will enable it to better compete for study participants for its midstage clinical trial of a drug for diabetic nephropathy.
  • M&A Terms
  • Venture Investor

Trending on Xconomy